Franklin Resources’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Franklin Resources’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-963,700	Closed	-$8.88M	–	1578
2017 Q1	$8.88M	Hold	963,700	–	–	﹤0.01%	988
2016 Q4	$7.43M	Sell	963,700 -30,200	-3%	-$277K	﹤0.01%	1024
2016 Q3	$11.4M	Buy	993,900 +700,000	+238%	+$8.15M	0.01%	949
2016 Q2	$3.62M	Hold	293,900	–	–	﹤0.01%	1150
2016 Q1	$2.97M	Hold	293,900	–	–	﹤0.01%	1195
2015 Q4	$6.63M	Buy	293,900 +14,500	+5%	+$297K	﹤0.01%	1083
2015 Q3	$4.63M	Buy	279,400 +30,100	+12%	+$603K	﹤0.01%	1160
2015 Q2	$5.61M	Hold	249,300	–	–	﹤0.01%	1159
2015 Q1	$6.43M	Hold	249,300	–	–	﹤0.01%	1137
2014 Q4	$5.42M	Hold	249,300	–	–	﹤0.01%	1179
2014 Q3	$4.72M	Sell	249,300 -8,600	-3%	-$173K	﹤0.01%	1194
2014 Q2	$6.01M	Buy	257,900 +21,100	+9%	+$521K	﹤0.01%	1151
2014 Q1	$7.97M	Hold	236,800	–	–	﹤0.01%	1077
2013 Q4	$6.99M	Buy	236,800 +18,200	+8%	+$333K	﹤0.01%	1075
2013 Q3	$3.35M	Buy	+218,600	New	+$4.05M	﹤0.01%	1176

Other funds holding OMED

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Franklin Resources's OMED Position: Q2 2017 in Review

Franklin Resources sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2017, closing a stake of 963,700 shares — an estimated $8.88M sold.

Franklin Resources first reported a position in OMED in Q3 2013 and held it in 15 quarters. The position peaked at $11.4M in Q3 2016. 68 funds tracked by Wall St. Rank hold OMED as of Q2 2017.

Franklin Resources reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Franklin Resources sold 963,700 OncoMed Pharmaceuticals, Inc. shares in Q2 2017, an estimated $8.88M.
Franklin Resources first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 15 quarters.
Franklin Resources's OncoMed Pharmaceuticals, Inc. position peaked at $11.4M in Q3 2016.
68 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2017.

Based on Franklin Resources's 13F filing for Q2 2017, filed 10 Aug 2017.